LakeShore Biopharma Co., Ltd (OTCPK: LSBC.F)
Health Care · Biotechnology · CN
$—
— today · — 1Y
LakeShore Biopharma Co., Ltd (OTCPK: LSBC.F) operates in the Biotechnology industry within the Health Care sector.
trading between 0.03 and 1.23.
Tweenvest scores LakeShore Biopharma Co., Ltd across four factors: quality 34/100, value 43/100. Its strongest factor is value.
LSBC.F price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- —
- Revenue (TTM)
- $84.75M
- P/E
- —
- EPS
- -5.22
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $1.23
- 52-week low
- $0.03
- Avg volume (3M)
- —
- Shares outstanding
- —
- Employees
- 758
- Next earnings
- —
About LakeShore Biopharma Co., Ltd
LakeShore Biopharma Co., Ltd, a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. LakeShore Biopharma Co., Ltd was founded in 2002 and is based in Beijing, China.
- ISIN
- KYG9845F2080
- Founded
- 1994
- Listed since
- Aug 5, 2021
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $266.00 | +0.08% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $442.45 | +0.05% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.74 | -0.02% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $552.00 | -0.15% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $832.63 | -0.11% |
| argenx SEENXTBR: ARGX | $64.17B | €909.60 | +3.46% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $157.49 | -0.84% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.